Expansion of the Innovative Therapies Program to Include the Development of a Pediatric Neuro-Oncology Translational Research Program |
Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta / Howard Katzenstein, MD |
Phase I/II Infrastructure Grants |
2010 |
Georgia |
The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma |
Emory University / Anna Kenney, PhD |
Innovation Grants |
2019 |
Georgia |
Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors |
University of Florida / Catherine Flores, PhD |
Young Investigator Grants |
2015 |
Florida |
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida / Catherine Flores, PhD |
Innovation Grants |
2019 |
Florida |
Phase I trial of multilamellar mRNA lipid particles for recurrent pediatric high grade glioma |
University of Florida / Elias Sayour, MD/PhD |
R Accelerated Award Grants |
2022 |
Florida |
LRP1 and Angiogenesis in Pediatric Malignant Glioma |
Mayo Clinic Jacksonville / Takahisa Kanekiyo, MD, PhD |
Young Investigator Grants |
2013 |
Florida |
Treatment for human hepatoblastoma based on recombinant adeno-associated virus vectors |
University of Florida / Chen Ling |
Young Investigator Grants |
2012 |
Florida |
Casein Kinase 1 alpha Agonists as Novel Medulloblastoma Inhibitors |
University of Miami Miller School of Medicine / David Robbins, PhD |
Innovation Grants |
2012 |
Florida |
Molecular Landscape for Targeted Therapy in Retinoblastoma |
University of Miami / James Harbour, MD |
Innovation Grants |
2018 |
Florida |
Expanding Hope: Innovative Therapy at Shands Children's Hospital |
University of Florida / Amy Smith |
Phase I/II Infrastructure Grants |
2010 |
Florida |